Some new, highly selective, and sensitive colorimetric pH indicators, spiro[4H-indeno-[1,2-b]pyridine-4,3'-[3H]indoles] (SIPIs) in aqueous solution were developed. SIPIs were synthesized via a one-pot four-component condensation of isatin derivatives, β-diketones 1,3-indandione, and ammonium acetate using FSi-PrNH-BuSOH as a nanocatalyst in EtOH. According to the experimental evaluations, it was found that SIPI derivatives are pH indicators for naked-eye detection of OH- ion with intense color changes from orange to purple in the pH range of 10.
View Article and Find Full Text PDFPurpose/background: This double-blind, placebo-controlled clinical trial was designed to assess the efficacy and safety of memantine augmentation to standard regimen of antipsychotic treatment on psychotic symptoms and cognitive function in individuals with chronic schizophrenia for 8 weeks.
Methods/procedures: Forty stabilized individuals with chronic schizophrenia were randomized in a 1:1 ratio to memantine (20 mg/d) and control (placebo) groups, along with their antipsychotic regimen for 8 weeks. The efficacy of treatment was assessed by the Positive and Negative Syndrome Scale (PANSS) and Brief Assessment of Cognition Scale, and the safety was measured by the Abnormal Involuntary Movement Scale and Barnes Akathisia Rating Scale at baseline and at weeks 4 and 8.
Background: Iranian female methadone patients are at risk of human immunodeficiency virus (HIV) due to involvement in high-risk sexual behaviours and/or needle sharing. The present study aimed to explore the perceived educational needs related to HIV among a group of Iranian female methadone patients.
Methods: The research design was qualitative and the participants were sampled purposively.
Background And Objective: Today, the role of oxidative stress in development of schizophrenia has gained attention. Also, some atypical antipsychotic agents showed antioxidant properties. Therefore, in this study, we evaluated the level of oxidative stress parameters between patients treated with perphenazine, clozapine and risperidone and their relationship with schizophrenia symptoms' severity.
View Article and Find Full Text PDF